Novo Nordisk sues Eli Lilly over misleading obesity treatment advertising

Novo Nordisk is suing Eli Lilly in the United States for 'misleading advertising' regarding obesity treatments.

Published 9h2 sources✓ ConfirmedNotableupdated 9h

≈ 19sSpeed

The fact

The Danish company accuses its rival of downplaying side effects of its medications.

This legal battle could impact the obesity therapy market.

2 sources — click a link to read an article on the topic:

Explore this topic

Auto-synthesis from 2 media sources · identified on July 21, 2026